维普中文期刊产品整合服务
19篇 您的检索式:作者名="Tallen"
    题名 作者 年代 出处 被引量
1Keep - ING balance : Tumor suppres- sion by epigenetie regulation 显示文摘Tallen G Riabowol K 2014FEBS Lett2014,588,16:1
2Long-term outcome in children with relapsed acute lymphoblastic leukemia after timepoint and site-of-relapse stratification and intensified short-course multidrug chemotherapy: results of trial ALL-REZ BFM 90显示文摘Tallen G Ratei R Mann G 2010J ClinOncol2010,28,14:1
3Anatomic disorders of thetempormandibular joint disc in asymptomatic subjects显示文摘Katzberg RW Westesson RL Tallens RH 1996J Oral Maxillofac Surg1996,54,:1
4Down-regulation of the inhibitor of growth 1 (ING1) tumor suppressor sensitizes p53-deficient gfioblastoma cells to cisplatin-induced cell death显示文摘Tallen UG Truss M Kunitz F 2008J Neurooncol2008,86,1:1
5Down-regulation of the inhibitor of growth 1 (ING1) tumor suppressor sensitizes p53- deficient glioblastoma cells to eisplatininduced cell death 显示文摘Tallen U G Truss M Kunitz F 2008J Neurooncol2008,86,1:1
6No ING1 mutations in human brain tumor but reduced expression in high malignancy grades of astrocytoma显示文摘Tallen G Kaise I Krabbe S 2004Int J Cancer2004,109,3:1
7Long-term outcome in children with relapsed acute lymphoblastic leukemia after time-point and site-of-relapse stratification and intensified short-course multidrug chemotherapy:results of trial ALL-REZ BFM 90显示文摘Tallen G Ratei R Mann G 2010J Clin Oncol2010,28,14:1
8Long-term outcome in children with relapsed acute lymphoblastic leukemia after time-point and site-of-relapse stratification and intensified short-course multidrug chemotherapy:Results of trial ALL-REZ BFM 90显示文摘Tallen G Ratei R Mann G 2010J Clin Oncol2010,28,14:1
9Expression of p33ING1 mRNA and chemosensitivity in brain tumor cells显示文摘TALLEN G RIABOWOL K WOLFF J E 2003Anticancer Res2003,23,2:1
10Long-term outcome in children with relapsed acute lymphoblastic leukemia after time-point and site-of-relapse stratification and intensified short-course multidrug chemotherapy:results of trial ALL-REZ BFM 90显示文摘Tallen G Ratei R Mann G 2010J Clin Oncol2010,28,:1
11Down-regulation of the Inhibitor of Growth 1 (ING1) Tumor Suppressor Sensitizes p53-deficient Glioblastoma Cells Tocisplatin Induced Cell Death显示文摘Tallen U G Truss M Kunitz F 2008J Neurooncol2008,86,1:1
12Down-regulation of the in- hibitor of growth 1 ( ING1 ) tumor suppressor sensitizes p53-defi- cient glioblastoma cells to cisplatin-induced cell death 显示文摘Tallen UG Truss M Kunitz F 2008J Neurooncol2008,86,1:1
13No ING1 mutations in human brain tumours but reduced expression in high malignancy grades of astrocytoma显示文摘Tallen G Kaiser I Krabbe S 2004Int J Cancer2004,109,3:1
14No INGI mutations in human brain tumours but reduced expression in high malignancy grades of astrocytoma显示文摘Tallen G Kaiser I Krabbe S 2004Int J Cancer2004,109,3:1
15Expression of p^33ING1 mRNA and chemosensitivity in brain tumor cells显示文摘Tallen G Riabowol K Wolff J E 2003Anticancer Res2003,23,2:1
16Long-term outcome in children with relapsed acute lymphoblastic leukemia after time-point and site-of-relapse stratification and intensified short-course multidrug chemotherapy:results of trial ALL-REZ BFM 90显示文摘Tallen G Ratei R Mann G 0,,14:1
17The inhibitor of growth 1 ( ING1 ) proteins suppress angiogenesis and differentially regulate angiopoietin expression in glioblastoma ceils 显示文摘TALLEN G FARHANGI S TAMANNAI M 2009Oncol Res2009,18,23:1
18Long-termoutcome in children with relapsed acute lymphoblasticleukemia after time-point and site-of-relapse stratifica-tion and intensified short-course multidrug chemothera-py: results of trial ALL-REZ BFM 90显示文摘TALLEN G RATEI R MANN G 2010J Clin On-col2010,28,14:1
19Long-term outcome in children with relapsed acute lymphoblastic leukemia after time-point and site- of-relapse stratification and intensified short-course muhidrug chemo- therapy: results of trial ALL-REZ BFM 90显示文摘Tallen G Ratei R Mann G 2010J Clin Onto12010,28,14:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费